Akèy › Skleroderm Difize › Texas › Dallas
Etid klinik pou Skleroderm Difize nan Dallas, TX
3 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
- Baylor Scott & White Research Institute, Dallas
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Dallas
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Red Oak, Red Oak · 18 mi lwen
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Ann Arbor, MI7 etid
- Chicago, IL7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Baltimore, MD5 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
- Kansas City, KS4 etid
- Philadelphia, PA4 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.